ACR Appropriateness Criteria external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.
作者信息
Zaorsky Nicholas G, Showalter Timothy N, Ezzell Gary A, Nguyen Paul L, Assimos Dean G, D'Amico Anthony V, Gottschalk Alexander R, Gustafson Gary S, Keole Sameer R, Liauw Stanley L, Lloyd Shane, McLaughlin Patrick W, Movsas Benjamin, Prestidge Bradley R, Taira Al V, Vapiwala Neha, Davis Brian J
机构信息
Fox Chase Cancer Center, Philadelphia, Pennsylvania (research author).
University of Virginia, Charlottesville, Virginia (principal author).
出版信息
Adv Radiat Oncol. 2016 Oct 20;2(1):62-84. doi: 10.1016/j.adro.2016.10.002. eCollection 2017 Jan-Mar.
Abstract
摘要
相似文献
1
ACR Appropriateness Criteria external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.
Adv Radiat Oncol. 2016 Oct 20;2(1):62-84. doi: 10.1016/j.adro.2016.10.002. eCollection 2017 Jan-Mar.
2
ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.
Am J Clin Oncol. 2011 Dec;34(6):636-47. doi: 10.1097/COC.0b013e3182354a65.
3
ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):667-72. doi: 10.1016/j.ijrobp.2008.12.073. Epub 2009 Apr 20.
4
ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.
Brachytherapy. 2017 Mar-Apr;16(2):266-276. doi: 10.1016/j.brachy.2016.10.002. Epub 2016 Dec 7.
5
6
Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology. 2000 Jun;215 Suppl:1441-8.
7
8
Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.
J Urol. 2006 Oct;176(4 Pt 1):1399-403. doi: 10.1016/j.juro.2006.06.045.
9
Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
Brachytherapy. 2008 Jan-Mar;7(1):17-21. doi: 10.1016/j.brachy.2007.11.002. Epub 2008 Jan 16.
10
Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Radiology. 2000 Jun;215 Suppl:1449-72.
引用本文的文献
1
Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Men With Hip Prostheses: A Cautionary Note.
Cureus. 2024 May 31;16(5):e61432. doi: 10.7759/cureus.61432. eCollection 2024 May.
2
Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey.
Adv Radiat Oncol. 2022 Feb 3;7(5):100902. doi: 10.1016/j.adro.2022.100902. eCollection 2022 Sep-Oct.
3
Assessing Inter-Fraction Changes in The Size and Position of The Penile Bulb During Daily MR-Guided Radiation Therapy to The Prostate Bed: Do We Need to Adjust How We Plan Radiation in The Post-Radical Prostatectomy Setting to Reduce Risk of Erectile Dysfunction?
Clin Genitourin Cancer. 2022 Jun;20(3):e227-e232. doi: 10.1016/j.clgc.2022.01.006. Epub 2022 Jan 11.
4
Salvage therapy for prostate cancer after radical prostatectomy.
Nat Rev Urol. 2021 Nov;18(11):643-668. doi: 10.1038/s41585-021-00497-7. Epub 2021 Aug 6.
5
Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance imaging-based prostate radiotherapy.
Phys Imaging Radiat Oncol. 2018 Dec 7;8:51-56. doi: 10.1016/j.phro.2018.11.007. eCollection 2018 Oct.
6
MRI-Based Proton Treatment Planning for Base of Skull Tumors.
Int J Part Ther. 2019 Fall;6(2):12-25. doi: 10.14338/IJPT-19-00062.1. Epub 2019 Sep 30.
7
Late toxicity after post-prostatectomy intensity modulated radiation therapy: Evaluating normal-tissue sparing guidelines.
Adv Radiat Oncol. 2018 May 8;3(3):339-345. doi: 10.1016/j.adro.2018.04.009. eCollection 2018 Jul-Sep.
8
Intensity-modulated radiotherapy for prostate cancer.
Transl Androl Urol. 2018 Jun;7(3):297-307. doi: 10.21037/tau.2017.12.16.
9
Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer.
Sci Rep. 2018 Jul 12;8(1):10538. doi: 10.1038/s41598-018-28730-1.
10
The evolution of brachytherapy for prostate cancer.
Nat Rev Urol. 2017 Jun 30;14(7):415-439. doi: 10.1038/nrurol.2017.76.
本文引用的文献
1
Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer.
Cancer. 2015 Sep 1;121(17):3010-7. doi: 10.1002/cncr.29472. Epub 2015 May 29.
2
Anterior-oriented proton beams for prostate cancer: A multi-institutional experience.
Acta Oncol. 2015 Jun;54(6):868-74. doi: 10.3109/0284186X.2014.986288. Epub 2015 Jan 16.
3
Cancer statistics, 2015.
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
4
ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.
Oncology (Williston Park). 2014 Dec;28(12):1125-30, 1132-6.
5
Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study.
Front Oncol. 2014 Nov 26;4:319. doi: 10.3389/fonc.2014.00319. eCollection 2014.
6
Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques.
Pract Radiat Oncol. 2015 May-Jun;5(3):e215-e222. doi: 10.1016/j.prro.2014.09.004. Epub 2014 Oct 30.
7
Effect of metal hip prosthesis on the accuracy of electromagnetic localization tracking.
Pract Radiat Oncol. 2015 Jan-Feb;5(1):43-8. doi: 10.1016/j.prro.2014.03.010. Epub 2014 May 14.
8
Stereotactic ultrasound for target volume definition in a patient with prostate cancer and bilateral total hip replacement.
Pract Radiat Oncol. 2015 May-Jun;5(3):197-202. doi: 10.1016/j.prro.2014.08.008. Epub 2014 Sep 26.
9
Local recurrence map to guide target volume delineation after radical prostatectomy.
Pract Radiat Oncol. 2014 Nov-Dec;4(6):e239-46. doi: 10.1016/j.prro.2014.02.007. Epub 2014 Apr 16.
10
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.
Front Oncol. 2014 Oct 28;4:301. doi: 10.3389/fonc.2014.00301. eCollection 2014.
Zotero 插件